Neuromuscular blockade with anti-axoplasmic antibodies.
In the process of developing an immunopharmacologic method for identifying a "trophic" protein released from motor nerve terminals, a soluble fraction of peripheral nerve axoplasm was prepared. An attempt was made to eliminate contaminating myelin and basic protein. Antibodies were produced to soluble nerve proteins in all sheep immunized. On boosting, after a 6-week interval, the animals became weak, and some could not stand on the fifth day after injection. A distinct component of neuromuscular blockade was demonstrated electrically and in response to edrophonium. Because this syndrome was (1) in the broadest sense, an experimental allergic neuropathy but produced by a distinctly different antigen than has been utilized previously (the soluble nerve proteins represented the axoplasmic compartment) and (2) a clinical condition associated with a defect in neuromuscular transmission, this may represent a new and potentially important model in the study of neuromuscular and other neurologic diseases.
D000818:Animals; D000906:Antibodies; D000941:Antigens; D001369:Axons / Q000276:immunology*; D002795:Choline O-Acetyltransferase / Q000032:analysis; D003593:Cytoplasm / Q000276:immunology; D004491:Edrophonium / Q000494:pharmacology; D009419:Nerve Tissue Proteins / Q000032:analysis / Q000276:immunology*; D009443:Neuritis / Q000276:immunology; D009469:Neuromuscular Junction / Q000187:drug effects / Q000276:immunology*; D051381:Rats; D012584:Sciatic Nerve / Q000201:enzymology; D012756:Sheep; D009435:Synaptic Transmission / Q000187:drug effects
D000906:Antibodies; D000941:Antigens; D009419:Nerve Tissue Proteins; D004491:Edrophonium; D002795:Choline O-Acetyltransferase